These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 6697736

  • 1. Increased circulating plasma norepinephrine concentrations in noncardiac causes of pulmonary hypertension.
    Zaloga GP, Chernow B, Fletcher JR, Hughes P, Rainey TG, Lake CR.
    Crit Care Med; 1984 Feb; 12(2):85-9. PubMed ID: 6697736
    [Abstract] [Full Text] [Related]

  • 2. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM, Hare JM, Loh E, Gauthier DF, Colucci WS.
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [Abstract] [Full Text] [Related]

  • 3. [Pulmonary plasma catecholamine levels and pulmonary hypertension in congenital heart disease].
    Knirsch W, Eiselt M, Nürnberg J, Haas NA, Berger F, Dähnert I, Uhlemann F, Lange PE.
    Z Kardiol; 2002 Dec; 91(12):1035-43. PubMed ID: 12490993
    [Abstract] [Full Text] [Related]

  • 4. Successful weaning from cardiopulmonary bypass with central venous prostaglandin E1 and left atrial norepinephrine infusion in patients with acute pulmonary hypertension.
    Tritapepe L, Voci P, Cogliati AA, Pasotti E, Papalia U, Menichetti A.
    Crit Care Med; 1999 Oct; 27(10):2180-3. PubMed ID: 10548203
    [Abstract] [Full Text] [Related]

  • 5. Adenosine as a vasodilator in primary pulmonary hypertension.
    Morgan JM, McCormack DG, Griffiths MJ, Morgan CJ, Barnes PJ, Evans TW.
    Circulation; 1991 Sep; 84(3):1145-9. PubMed ID: 1884445
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension.
    Ricci GL, Melgosa MT, Burgos F, Valera JL, Pizarro S, Roca J, Rodriguez-Roisin R, Barberà JA.
    Liver Transpl; 2007 Nov; 13(11):1506-14. PubMed ID: 17969197
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A comparative study of the vasodilator effects of prostaglandin E1 in patients with pulmonary hypertension after mitral valve replacement and with adult respiratory distress syndrome.
    Kunimoto F, Arai K, Isa Y, Koyano T, Kadoi Y, Saito S, Goto F.
    Anesth Analg; 1997 Sep; 85(3):507-13. PubMed ID: 9296401
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Contrasting acute effects of vasodilators (nitroglycerin, nitroprusside, and hydralazine) on right ventricular performance in patients with chronic obstructive pulmonary disease and pulmonary hypertension: a combined radionuclide-hemodynamic study.
    Brent BN, Berger HJ, Matthay RA, Mahler D, Pytlik L, Zaret BL.
    Am J Cardiol; 1983 Jun; 51(10):1682-9. PubMed ID: 6407295
    [Abstract] [Full Text] [Related]

  • 15. Pulmonary vascular resistance in neonatal swine: response to right pulmonary artery occlusion, isoproterenol, and prostaglandin E1.
    Crombleholme TM, Adzick NS, Longaker MT, Bradley SM, Duncan BW, Jennings R, Verrier ED, Harrison MR.
    J Pediatr Surg; 1990 Aug; 25(8):861-6. PubMed ID: 2401941
    [Abstract] [Full Text] [Related]

  • 16. The distribution of plasma norepinephrine concentration and the relation of plasma norepinephrine concentration to pulmonary arterial pressure in heart disease.
    Kondo T, Ogawa K, Ban M, Watanabe E, Satake T.
    Jpn Circ J; 1981 Nov; 45(11):1243-9. PubMed ID: 7300005
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil.
    Melenovsky V, Al-Hiti H, Kazdova L, Jabor A, Syrovatka P, Malek I, Kettner J, Kautzner J.
    J Am Coll Cardiol; 2009 Aug 11; 54(7):595-600. PubMed ID: 19660688
    [Abstract] [Full Text] [Related]

  • 19. Pulmonary vasodilator effects of norepinephrine during the development of chronic pulmonary hypertension in neonatal lambs.
    Jaillard S, Elbaz F, Bresson-Just S, Riou Y, Houfflin-Debarge V, Rakza T, Larrue B, Storme L.
    Br J Anaesth; 2004 Dec 11; 93(6):818-24. PubMed ID: 15465842
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.